FdaApplication
ANDA 210721
Identifiers
- fda_app_no: ANDA210721
Properties
| Property | Value |
|---|---|
| applicant_name | APOTEX INC |
| application_type | ANDA |
| approval_date | 2019-07-10 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CYCLOSPORINE | CYCLOSPORINE | 50MG | CAPSULE;ORAL |
| CYCLOSPORINE | CYCLOSPORINE | 25MG | CAPSULE;ORAL |
| CYCLOSPORINE | CYCLOSPORINE | 100MG | CAPSULE;ORAL |
3 products